Previous Close | 7.48 |
Open | 7.48 |
Bid | 8.10 |
Ask | 10.60 |
Strike | 7.50 |
Expire Date | 2024-08-16 |
Day's Range | 7.48 - 7.48 |
Contract Range | N/A |
Volume | |
Open Interest | 3 |
FT. MYERS, Fla., May 28, 2024--NeoGenomics will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at ASCO 2024 in Chicago (booth #31093).
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript April 30, 2024 NeoGenomics, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03. NEO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the NeoGenomics First Quarter 2024 Financial […]
NeoGenomics ( NASDAQ:NEO ) First Quarter 2024 Results Key Financial Results Revenue: US$156.2m (up 14% from 1Q 2023...